Grant Pharmaceutical Companies

Eikonizo Therapeutics is a biopharmaceutical company.

Perlara, PBC is precision drug discovery that leaves no mutation behind.

Kernalbio creates mRNA therapies that instruct specific cells on how to make their own medicine.

Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.

Bioscibex is a single-use bioreactor systems designed for the production of contemporary biologics and cell therapies.

ProVascTec is a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system.

Küleon Bioscience a drug discovery business, uses patented, AI-based technologies.

Scanogen is a molecular diagnostic company.

Cellestial Health is a preclinical biopharmaceutical company.

Vast Therapeutics is an innovative, preclinical-stage pharmaceutical company .

Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.

Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patients

AI-accelerated Participant Relationship Management (PRM) for Clinical Research

Civica is a non-profit generic drug company used to help patients by addressing shortages and high prices of lifesaving medications.

Akyso is a biotechnology company that offers treatment solutions for rehabilitation and medication for opioid use disorder.

Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.

Robotic Embodiment Platform for Life Science Industry

MetasTx is creating treatments that prevent and treat prostate cancer metastasis without affecting the Androgen System.

Revolutionizing infection prevention by using nanotechnology to deliver ultra-fast, lab quality microbial testing at the point of sampling.

RevolKa is a biotechnology firm that manufactures bio-products pharmaceuticals intended to serve the healthcare sector.

Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.

Inosi Therapeutics develop therapies to address fibrosis.

AI-powered treatment response prediction from 2-min rs-fMRI, optimizing neuropsychiatric trials and saving up to $116M per approved drug.

Molecule. one develops software for organic synthesis design.

Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.